ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1262

Magnolin Inhibits Renal Carcinoma Cell Metastasis by Targeting TGF-β1/SMAD/AP1-Mediated MMP-9 Expression

Session Information

Category: Onconephrology

  • 1600 Onconephrology

Authors

  • Tsai, Jen Pi, Dalin Tzu Chi Hospital, Dalin, Taiwan Province, Taiwan
  • Hsieh, Yi-Hsien, Chung Shan Medical University, Taichung, Taichung City, Taiwan
Background

Over the past decade, renal carcinoma cell (RCC) incidence has increased markedly. Targeted and immune therapies for advanced disease often cause nephrotoxicity. Thus, developing effective therapies with minimal renal toxicity is a priority. Magnolin, from Magnolia officinalis, shows anti-inflammatory and anti-cancer effects. However, its antitumor effects on RCC cells and underlying mechanisms remain unclear.

Methods

Cell viability, migration, and invasion were evaluated by MTT, flow cytometry, colony formation, and Transwell assays. Gene and protein expression were analyzed by qRT-PCR and western blotting. TCGA identified MMP9/TGF-β1 as targets. Immunofluorescence and ChIP confirmed pathway regulation. In vivo assays validated anti-metastatic efficacy and safety.

Results

Magnolin suppresses RCC cell proliferation, migration, and invasion, likely via downregulation of MMP-9. Magnolin inhibits TGF-β1 transcription and translation, blocks SMAD2/3 phosphorylation and nuclear translocation, and reduces AP-1 (c-Jun/c-Fos) expression, thereby decreasing MMP-9 transcriptional activity. Consequently, Magnolin inhibits RCC cell migartion and invasion. In vivo, it significantly reduces lung metastasis without evident systemic toxicity.

Conclusion

This study provides the first key evidence that Magnolin suppresses renal cell carcinoma metastasis by targeting the TGF-β1/SMAD/AP1-mediated MMP-9 pathway, supporting its potential as a natural therapeutic agent against RCC.

Funding

  • Other NIH Support